Concepedia

Benjamin J. Maldonato

BJ

Statistics

Publications

4

Citations

388

H-Index

4

Active since

2021

Affiliations

Revolution Medicines (United States)(Current)

Broad Institute

Harvard University

Dana-Farber Cancer Institute

University of Washington

Benjamin J. Maldonato is an author at Revolution Medicines (United States) specializing in drug metabolism, pharmacology, and dna methylation.

ORCID

Publications per year

2021–2025

4

Publications

4

Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

Jingjing Jiang, Lingyan Jiang, Benjamin J. Maldonato et al. · Cancer Discovery · 2024 · 281 citations · Full text

, , +17

Human METTL7B is an alkyl thiol methyltransferase that metabolizes hydrogen sulfide and captopril

Benjamin J. Maldonato, Drake A. Russell, Rheem A. Totah · Scientific Reports · 2021 · 54 citations · Full text

, , +14

A neomorphic protein interface catalyzes covalent inhibition of RAS <sup>G12D</sup> aspartic acid in tumors

Caroline E. Weller, G. Leslie Burnett, Lingyan Jiang et al. · Science · 2025 · 31 citations

, , +15

METTL7A (TMT1A) and METTL7B (TMT1B) Are Responsible for Alkyl S-Thiol Methyl Transferase Activity in Liver

Drake A. Russell, Marvin K. Chau, Yuanyuan Shi et al. · Drug Metabolism and Disposition · 2023 · 22 citations · Full text

, , +9

1–4 of 4